Pharmacokinetics of Re-188-nanodiamonds complex in mice bearing experimental Ehrlich carcinoma

«Radiation and Risk», 2017, vol. 26, No. 2, pp.62-71

DOI: 10.21870/0131-3878-2017-26-2-62-71

Authors

Petriev V.M.1,2 – Lead. Researcher, D. Sc., Biol., Prof. of MEPhI. A. Tsyb MRRC. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249036. Tel.: (484) 399-71-00; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Tishchenko V.K.1 – Senior Researcher, C. Sc., Biol.;
Mikhailovskaya A.A.1 – Senior Researcher; C. Sc., Biol.;
Konoplyannikov A.G.1 – Head of Dep., D. Sc., Biol., Prof. A. Tsyb MRRC.

Abstract

Targeted radionuclide therapy of tumors is one of the most active areas of research in precision cancer treatment. Nanodiamonds (NDs) have attracted enhanced attention as potential radionuclide carriers for targeting of cancer. The authors present results of the study of pharmacokinetic properties of NDs labeled with 188Re (188Re-NDs) according to a route of the drug administration. Experimental research was carried out on mice with the solid form of Ehrlich tumor, the labeled NDs were administered intratumorally, intravenously and intragastrically. Pharmacokinetic properties of carrier-free sodium perrhenate (Na188ReO4) after intratumoral administration served as control. Obtained data demonstrated that maximum specific radioactivity, 98.5%/g in the tumor, was after intratumoral administration of 188Re-NDs, and then it was cleared from the tumor very rapidly. The maximum of specific radioactivity in the tumor following intravenous and intragastrical administration of the 188Re-NDs complex were 2.85%/g and 3.14%/g respectively. Concentration of carrier-free Na188ReO4 in the tumor was considerably lower as compared with the concentration of 188Re-ND complex. High level of the 188Re-ND complex was detected in the thyroid and the stomach. Results of the study show that the highest level of radioactivity in the tumor was detected after intratumoral administration of the Na188ReO4-ND complex. A route of administration of the Na188ReO4-NDs complex did not effect considerably on the level of radioactivity in internal organs and tissues, however, the rate of accumulation of radioactivity in these organs and tissues depended on the route of administration.

Key words
nanoparticles, nanodiamonds, 188Re, radiopharmaceutical, Ehrlich carcinoma, radionuclide therapy, cancer therapy, intratumoral injection, intravenous injection, intragastric injection.

References

1. Schrand A.M., Huang H., Carlson C., Schlager J., Osawa E., Hussain S., Dai L. Are diamond nanoparticles cytotoxic? J. Phys. Chem. B., 2007, vol. 111, no. 1, pp. 2-7.

2. Mochalin V., Shenderova O., Ho D., Gogotsi Y. The properties and applications of nanodiamonds. Nat. Nanotechnol., 2012, vol. 7, no. 1, pp. 11-23.

3. Huang H., Pierstorff E., Osawa E., Ho D. Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett., 2007, vol. 7, no. 11, pp. 3305-3314.

4. Xiao J., Duan X., Yin Q., Zhang Z., Yu H., Li Y. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer. Biomaterials, 2013, vol. 34, no. 37, pp. 9648-9656.

5. Wang X., Low X.C., Hou W., Abdullah L.N., Toh T.B., Mohd Abdul Rashid M., Ho D., Chow E.K. Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. ACSociety Nano, 2014, vol. 8, no. 12, pp. 12151-12166.

6. Man H.B., Kim H., Kim H.J., Robinson E., Liu W.K., Chow E.K., Ho D. Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia. Nanomed., 2014, vol. 10, no. 2, pp. 359-369.

7. Guan B., Zou F., Zhi J. Nanodiamond as the pH-responsive vehicle for an anticancer drug. Small, 2010, vol. 6, no. 14, pp. 1514-1519.

8. Liu K.K., Zheng W.W., Wang C.C., Chiu Y.C., Cheng C.L., Lo Y.S., Chen C., Chao J.I. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnol., 2010, vol. 21, no. 31, pp. 315106.

9. Toh T.B., Lee D.K., Hou W., Abdullah L.N., Nguyen J., Ho D., Chow E.K. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Mol. Pharmacol., 2014, vol. 11, no. 8, pp. 2683-2691.

10. Li J., Zhu Y., Ki W., Zhang X., Peng Y., Huang Q. Nanodiamonds as intracellular transporters of chemo-therapeutic drug. Biomaterials, 2010, vol. 31, no. 32, pp. 8410-8418.

11. Aleksenskiy A.E., Eydelman E.D., Vul A.Ya. Deagglomeration of detonation nanodiamonds. Nanosci. Nanotechnol. Lett., 2011, vol. 3, no. 1, pp. 68-74.

12. Perevedentseva E., Hong S.F., Huang K.J., Chiang L.T., Lee C.Y., Tseng Y.T., Cheng C.L. Nanodiamond internalization in cells and the cell uptake mechanism. J. Nanopart. Res., 2013, vol. 15, pp. 1834-1845.

13. Cuche A., Sonnefraud Y., Faklaris O., Garrot D., Boudou J.P., Sauvage T., Roch J.F., Treussart F., Huant S. Diamond nanoparticles as photoluminescent nanoprobes for biology and near-field optics. J. Lumin., 2009, vol. 129, no. 12, pp. 1475-1477.

14. Liu K.K., Wang C.C., Cheng C.L., Chao J.I. Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials, 2009, vol. 30, no. 26, pp. 4249-4259.

15. Kaur R., Badea I. Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems. Int. J. Nanomed., 2013, vol. 8, pp. 203-220.

16. Keremidarska M., Ganeva A., Mitev D., Hikov T., Presker R., Pramatarova L., Krasteva N. Comparative study of cytotoxicity of detonation nanodiamond particles with an osteosarcoma cell line and primary mesenchymal stem cells. Biotechnol. Biotechnol. Equip., 2014, vol. 28, no. 4, pp. 733-739.

17. Yuan Y., Chen Y.W., Liu J.H., Wang H., Liu Y. Biodistribution and fate of nanodiamonds in vivo. Diam. Relat. Mater., 2009, vol. 18, no. 1, pp. 95-100.

18. Zhang X.Y., Yin J.L., Kang C., Li J., Zhu Y., Li W., Huang Q., Zhu Z. Biodistribution and toxicity of nanodiamonds in mice after intratracheal instillation. Toxicol. Lett., 2010, vol. 198, no. 2, pp. 237-243.

19. Wei Q., Zhan L., Juanjuan B., Jing W., Jianjun W., Taoli S., Yian G., Wangsuo W. Biodistribution of co-exposure to multi-walled carbon nanotubes and nanodiamonds in mice. Nanoscale Res. Lett., 2012, vol. 7, no. 1, pp. 473-481.

20. Rojas S., Gispert J.D., Martin R., Abad S., Menchόn C., Pareto D., Victor V.M., Alvaro M., Garcia H., Herance J.R. Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. ACS Nano, 2011, vol. 5, no. 7, pp. 5552-5559.

Full-text article (in Russian)